Microscopic polyangiitis: Modern concepts and treatment options

QR Code

Microscopic polyangiitis: Modern concepts and treatment options

The article summarizes the modern concepts of microscopic polyangiitis (MPA), a primary ANCA-associated systemic necrotizing vasculitis without immune globulin deposition (pauci-immune) that affects mainly small vessels, while granulomatous inflammation is absent. Necrotizing glomerulonephritis is v...

Full description

Saved in:

Bibliographic Details
Main Authors:	I. T. Murkamilov, K. A. Aitbaev, V. V. Fomin, I. O. Kudaibergenova, F. A. Yusupov, Zh. A. Murkamilova, T. V. Beketova
Format:	Article
Language:	Russian
Published:	IMA PRESS LLC 2021-10-01
Series:	Научно-практическая ревматология
Subjects:	systemic vasculitis anca microscopic polyangiitis glomerulonephritis alveolitis myeloperoxidase proteinase 3 glucocorticosteroids rituximab cytostatics
Online Access:	https://rsp.mediar-press.net/rsp/article/view/3082
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Livedo racemosa as the presenting symptom of microscopic polyangiitis
by: Christine Li, BS, et al.
Published: (2025-09-01)

Myeloperoxidase‐Antibody Positivity and Progression to Microscopic Polyangiitis in Interstitial Lung Disease: A Case Series
by: Michael Hoskins, et al.
Published: (2025-07-01)

COVID-19 in a patient with granulomatosis with polyangiitis: Management tactics
by: E. F. Iskhakova, et al.
Published: (2023-03-01)

Granulomatosis with polyangiitis with severe lung involvement: efficacy of anti-B cell therapy with Rituximab
by: T. V. Beketova, et al.
Published: (2021-07-01)

Clinical and immunological variants of ANCA-associated systemic vasculitis: a look at the pulmonary fibrosis in microscopic polyangiitis with anti-myeloperoxidase antibodies and rheumatoid factor. Literature review and own observation
by: T. V. Beketova, et al.
Published: (2023-03-01)

ASYMPTOMATIC COURSE OF LUNG DAMAGE IN GRANULOMATOSIS WITH POLYANGIITIS (WEGENER’S)
by: Tat’yana V Beketova
Published: (2014-03-01)

Granulomаtosis With Polyangiitis Affecting the Lung and Orbit
by: Zh. V. Sheikh, et al.
Published: (2021-06-01)

The course and outcomes of COVID-19 in patients with ANCA-associated systemic vasculitis, receiving biological therapy (Rituximab, Mepolizumab): The results of the first 8 months of the pandemic
by: T. V. Beketova, et al.
Published: (2021-03-01)

THE 2016 EUROPEAN (EULAR/ERA-EDTA) RECOMMENDATIONS FOR THE DIAGNOSIS AND MANAGEMENT OF ANCA-ASSOCIATED SYSTEMIC VASCULITIS
by: T. V. Beketova
Published: (2017-03-01)

Upper respiratory tract manifestations in patients with ANCA-associated vasculitides and their association with the presence and type of ANCA
by: I. G. Smirnova, et al.
Published: (2021-10-01)

Review of guideline for the management of ANCA-associated vasculitis, presented in 2021 by the American College of Rheumatology/Vasculitis Foundation
by: T. V. Beketova, et al.
Published: (2021-12-01)

Rituximab versus azathioprine in maintenance therapy of patients with granulomatosis with polyangiitis
by: Samira Alesaeidi, et al.
Published: (2025-06-01)

RECURRENT ANCA-ASSOCIATED VASCULITIS AFTER KIDNEY ALLOTRANSPLANTATION
by: N. F. Frolova, et al.
Published: (2016-03-01)

Ten-year experience with rituximab for induction and maintenance therapy in patients with ANCA-associated systemic vasculitis
by: T. V. Beketova, et al.
Published: (2020-03-01)

Covid-19 in a patient with ANCA-associated systemic vasculitis, receiving anti-B cell therapy (rituximab)
by: T. V. Beketova, et al.
Published: (2020-09-01)

International guidelines for the management ofANCA-associated systemic vasculitides
by: T. V. Beketova
Published: (2019-03-01)

Treatment With Avacopan in ANCA–Associated Vasculitis With Kidney Involvement
by: Duvuru Geetha, et al.
Published: (2025-08-01)

Granulomatosis with polyangiitis, complicated by ocular adnexa lesion and vascular changes in retina and choroid (literature review with a clinical case)
by: P. V. Tolstov, et al.
Published: (2024-06-01)

CLINICAL AND RADIOLOGICAL CHARACTERISTICS OF ANCA-ASSOCIATED VASCULITIS: 7 YEARS OF EXPERIENCE IN DIAGNOSIS AND TREATMENT
by: L. M. Kudelya, et al.
Published: (2020-03-01)

New ACR/EULAR 2022 classification criteria for ANCA-associated vasculitis
by: T. V. Beketova
Published: (2023-10-01)

Circulating miRNAs as potential non-invasive biomarkers for ANCA-associated glomerulonephritis
by: Matic Bošnjak, et al.
Published: (2025-07-01)

Difficulties in the differential diagnosis of granulomatosis with polyangiitis and scarring pemphigoid
by: N. A. Magdeeva, et al.
Published: (2020-10-01)

Ocular Manifestations of COVID-19 in a Patient with ANCAAssociated Vasculitis Treated with Rituximab. A Case Report
by: M. D. Suprun, et al.
Published: (2022-07-01)

EXPERIENCE WITH EFFECTIVE COMBINED ANTI-B-CELL THERAPY WITH RITUXIMAB AND BELIMUMAB FOR REFRACTORY GRANULOMATOSIS WITH POLYANGIITIS (WEGENER'S) WITH SEVERE LUNG DAMAGE
by: T. V. Beketova, et al.
Published: (2017-03-01)

GRANULOMATOSIS WITH POLYANGIITIS, WHICH IS PATHOGENETICALLY ASSOCIATED WITH ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES: CLINICAL FEATURES
by: Tatiana Valentinovna Beketova
Published: (2012-12-01)

THE 2015 INTERNATIONAL GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS
by: T. V. Beketova, et al.
Published: (2016-07-01)

A clinical case of lung damage in granulomatosis with polyangiitis
by: A. Yu. Kraposhina, et al.
Published: (2021-10-01)

SARS-CoV-2-INDUCED MICROSCOPIC POLYANGIITIS: CLINICAL PROBLEM
by: Olga O. Gutsalenko, et al.
Published: (2025-05-01)

Combination Cyclophosphamide and Rituximab to Minimize Glucocorticoid Use in Antineutrophil Cytoplasm Antibody–Associated Vasculitis
by: Tania Salehi, et al.
Published: (2025-07-01)

Successful total hip arthroplasty in patients with anca-associated systemic vasculitis
by: T. V. Beketova, et al.
Published: (2019-11-01)

Arthritis as a clinical manifestation of antineutrophil cytoplasmic antibody-associated systemic vasculitis: diagnostic difficulties
by: T. V. Beketova, et al.
Published: (2018-06-01)

Eosinophilic granulomatosis with polyangiitis in comorbidpatient: is the immunological diagnostics always unambiguous
by: V. N. Marchenko, et al.
Published: (2020-04-01)

RUSSIAN EXPERIENCE WITH USING MONOCLONAL ANTIBODIES TO B-LYMPHOCYTES (RITUXIMAB) IN SYSTEMIC VASCULITIDES ASSOCIATED WITH NEUTROPHIL CYTOPLASMIC ANTIBODIES (PRELIMINARY RESULTS OF THE RUSSIAN REGISTER NORMA)
by: T. V. Beketova, et al.
Published: (2014-06-01)

THE ONSET OF ANCA-ASSOCIATED SYSTEMIC VASCULITIS MASKING RHEUMATOID ARTHRITIS
by: N. F. Frolova, et al.
Published: (2016-02-01)

Use of Avacopan as a Steroid-Sparing Medication in ANCA-associated Vasculitis Patients with Renal Impairment
by: Mitchell Salke, et al.
Published: (2025-06-01)

ANCA-associated vasculitis in a 14 years-old patient: a clinical case
by: A. V. Burlutskaya, et al.
Published: (2020-10-01)

Systemic vasculitides: сlinical cases
by: Valentina Nikolaevna Antipova, et al.
Published: (2015-09-01)

Neutralizing the Th1 effector cytokines, IFN-γ and TNF-α, attenuates established experimental autoimmune anti-myeloperoxidase glomerulonephritis
by: Kei Nagai, et al.
Published: (2025-07-01)

UNMASKING GRANULOMATOSIS WITH POLYANGIITIS: A DIAGNOSTIC ODYSSEY IN A PATIENT INITIALLY DIAGNOSED WITH GIANT CELL ARTERITIS
by: Yusuf Nawras, et al.
Published: (2025-06-01)

MPO-ANCA-Associated Hypertrophic Pachymeningitis Mimicking IgG4-Related Disease: A Case Report and Literature Review
by: Chen Y, et al.
Published: (2025-05-01)